Terpene oligomer hydrocarbons

The development of self-coupling reactions for terpenes using ene and Diels-Alder cycloadditions addresses inefficiencies in existing methods, producing sustainable hydrocarbons for cosmetic and industrial uses.

WO2026241350A1PCT designated stage Publication Date: 2026-11-19P2 SCIENCE INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/027921
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-12
Filing Date
2026-05-12
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing methods for producing hydrocarbons from terpenes require harsh reaction conditions and are limited by the reactivity of starting materials, making them inefficient and environmentally unfriendly.

Method used

A method for self-coupling reactions using ene reactions and Diels-Alder cycloadditions on unactivated hydrocarbon terpenes, forming novel terpene oligomers such as dimers, trimers, and tetramers, which can be further hydrogenated to produce sustainable hydrocarbons.

Benefits of technology

The method produces hydrocarbons with novel properties suitable for cosmetic, pharmaceutical, and personal care compositions, reducing environmental impact and providing sustainable ingredients for various industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000002_0001
    Figure IMGF000002_0001
  • Figure IMGF000002_0002
    Figure IMGF000002_0002
  • Figure IMGF000003_0001
    Figure IMGF000003_0001
Patent Text Reader

Abstract

The present disclosure is directed to certain novel, terpene-derived polycyclic hydrocarbons that are useful as additives for cosmetic, pharmaceutical, and personal care compositions. The hydrocarbons may be saturated or unsaturated, and may be derived from renewable resources, making them environmentally friendly.
Need to check novelty before this filing date? Find Prior Art

Description

TERPENE OLIGOMER HYDROCARBONSCROSS-REFERENCE TO RELATED APPLICATIONS This application is a PCT application which claims priority to, and the benefit of, U.S. Provisional Application Ser. No. 63 / 804,333, filed on May 12, 2025, the contents of which are hereby incorporate by reference in its entirety.FIELD

[0001] The present disclosure is directed to certain novel, terpene-oligomer hydrocarbons that are useful as additives for cosmetic, pharmaceutical, and personal care compositions. The hydrocarbons may be saturated or unsaturated, and may be derived from renewable resources, making them environmentally friendly.BACKGROUND

[0002] Natural products are a sought-after source of industrially useful chemicals because of their biorenewability. Industrial chemicals derived from natural gas, petroleum, and other nonrenewable sources are increasingly frowned upon because of the effect on the environment from their extraction as well as due to their limited nature and increasing costs associated with extraction. In contrast, the use of naturally occurring biological feedstocks effectively provides a solar-energy empowered source of chemical precursors and fuels for industry. Plants which are rapidly growing and provide high concentrations of useful biochemical feedstocks are particularly important.

[0003] For example, terpenes and terpene derivatives are a diverse, commercially sought after, and industrially important classes of natural products. Terpenes occur in all organisms and are particularly prevalent in plants, from which they can be isolated on an industrial scale. The ready commercial access and low-cost of terpenes continually drives innovation into their chemical derivatization which find use in polymer science, the flavor & fragrance industry, the cosmetic industry, the pharmaceutical industry, and as surfactants, plastic additives, and other industrial uses.

[0004] Terpenes are excellent starting materials for chemical synthesis derived from natural isoprene chemistry. Due to their unique compact structures and reactive olefin functionalities,these molecules have significant potential as feedstocks to generate hydrocarbon materials with application in cosmetics and personal care.

[0005] Common synthetically useful, hydrocarbon mono-terpenes available from plant matter, include the following:a-pinene P-pinene limonene camphene sabinene 3-carene

[0006] It has been disclosed that some terpenes undergo acid-catalyzed isomerization. For example, alpha-pinene and beta-pinene undergo acid-catalyzed interconversion and can also be isomerized to both limonene and camphene, while limonene can be isomerized to terpinolene, terpinenes, and cymene. See Harvey et al.. Energy Fuels, 24:267-273 (2010); see also Harvey et al., U.S. 8,227,651; see also Femendes et al., Applied Catalysis A: General, 318:108-120 (2007).

[0007] Numerous carbon-carbon bond forming reactions involving alkenes are known, one of which is the so-called “ene-reaction” (“ene-coupling reaction” or the “Alder-ene” reaction, after chemist Kurt Alder, who discovered the reaction in 1943). The ene reaction is a chemical reaction between an alkene with an allylic hydrogen (the ene) and a compound containing a multiple bond (the enophile), in order to form a new sigma-bond with migration of the ene double bond and a 1,5-hydrogen shift. The product is a substituted alkene with the double bond shifted to the allylic position. The mechanism is a pericyclic group transfer reaction:eneenophile

[0008] Enes can be any pi-bonded molecules, such as olefins, that contain at least one hydrogen atom at the allylic position, and generally it is the allylic hydrogen of the ene component which participates in the reaction. The enophile is also an olefin, although the reaction is most commonly performed using electrophilic olefins. Because the transformation is a pericyclic reaction, it usually requires highly activated substrates and / or high temperatures. Forexample, a classic ene-reaction is the formation of substituted cyclohexene from methylenecyclohexane and an activated alkene (e.g., Z is an ester, -C(O)OR):

[0009] Due to the harsh reaction conditions, most ene reactions reported in the literature involve activated enophiles, such as unsaturated aldehydes, unsaturated esters, unsaturated nitriles, and the like. However, under appropriate catalytic conditions, even non-activated hydrocarbon olefins can participate.

[0010] A mechanistically similar reaction to the ene reaction is the Diels-Alder reaction, a [4+2] cycloaddition, which involves a reaction between a diene component and a dienophile, analogously to the ene an enophile of the ene reaction:dienedienophile

[0011] Unlike the ene reaction, the Diels-Alder reaction necessarily results in the formation of a cyclic product in which the two starting materials are joined. Due to reactivity constraints, the Diels-Alder reaction is most commonly performed between an electron-poor dienophile, and an electron-rich diene, but under catalytic conditions, both less-reactive dienophiles and dienes can be made to react.

[0012] The products of both the ene reaction and the Diels- Alder reaction are themselves olefins, so they can further participate in additional ene reaction or Diels-Alder reaction steps. Moreover, these olefins can be hydrogenated to form the corresponding saturated hydrocarbons.

[0013] The present disclosure therefore provides novel terpene-derived hydrocarbons formed by ene reactions and / or Diels alder reactions on terpenes (e.g., mono-terpenes) and terpene derivatives (e.g., diene isomers). The resulting products have novel and useful properties as additives in cosmetic, pharmaceutical, and personal care compositions.BRIEF SUMMARY

[0014] The inventors of the present disclosure have developed a highly efficient method for performing self-coupling reactions using the ene reaction and the Diels-Alder cycloaddition reaction on un-activated, hydrocarbon terpenes, and hydrocarbon terpene derivatives, to provide novel terpene oligomer hydrocarbons. The product hydrocarbons may include dimers, trimers, tetramers, etc., of the starting terpene or terpene derivative. This is possible because the product of an ene reaction or Diels-Alder cycloaddition reaction is an olefin which can further participate in the same reaction with additional equivalents of the starting material terpene or terpene derivative.

[0015] In some embodiments, the terpenes are monoterpenes, such as monocyclic monoterpenes (e.g., limonene) or bicyclic monoterpenes (e.g., alpha-pinene, beta-pinene, camphene, sabinene, carene, or thujene). In other embodiments, the terpenes are diterpenes or triterpenes, or higher terpenes. In a particular embodiment, the terpene is beta-pinene. In another particular embodiment, the terpene is limonene.

[0016] In some embodiments a monocyclic or bicyclic mono-unsaturated terpene is reacted in an acid-catalyzed ene reaction to provide the desired product (bridged dimer, trimer, tetramer, etc.), preferably using a flow reactor with a solid phase acid catalyst.

[0017] For example, in a particular embodiment, the terpene is beta-pinene, and the resulting product is a bridged beta-pinene dimer, for example, as follows (depending on how the double bonds interact in the two reacting molecules):

[0018] By repeating the reaction, or performing the reaction for a longer period, higher oligomers may be provided, such as beta-pinene trimers and tetramers, and mixtures thereof:ene-couplingP-pineneP-pinene trimer -pinene tetramer

[0019] In another particular embodiment, the terpene is limonene. According to the same ene-coupling chemistry described above for beta-pinene, the following reactions may proceed:

[0020] Depending on which limonene double bonds participate and the orientation of the molecules, all of the following products may potentially form in the limonene ene-coupling:

[0021] For some of the ene-coupling reactions described herein, an initial acid-catalyzed double bond isomerization is necessary to provide the correct spatial arrangement for the ene-coupling reaction. For example, to generate the fourth dimer product shown above, one molecule of limonene must first isomerize to pseudolimonene:acid-cat isomerizationpseudolimoneneene-coupling

[0022] As noted for beta-pinene, the limonene reaction products can react further in ene-coupling reactions to form trimeric, tetrameric, and higher products, for example, the following trimers and tetramers:

[0023] In some embodiments, a double-ene coupling can occur to provide a polycyclic product. For example, limonene can undergo double ene-couplings as follows:

[0024] Under the acid-catalyzed ene-coupling reaction conditions employed, double bond isomerizations may occur in the product molecules to produce more thermodynamically stable arrangements, for example, isomerization of a disubstituted double bond to a trisubstituted double bond or isomerization of an exocyclic double bond to an endocyclic double bond. This can make the unsaturated product mixture complex. As a result, it is understood that any unsaturated structures disclosed herein may also exist in alternative isomeric forms and such forms are embraced by the present disclosure.

[0025] In some embodiments a mono-unsaturated bicyclic terpene is first isomerized to a diunsaturated monocyclic terpene, such as under acid-catalyzed conditions in a flow reactor, followed by Diels-Alder cycloaddition to form the desired product, preferably using a flow reactor with a solid phase acid catalyst. In other embodiments, the naturally-occurring terpene may be a diene which can directly undergo the Diels-Alder cycloaddition without first being isomerized. It is noted that the diene of a Diels-Alder cycloaddition is usually a 1,3-diene (conjugated diene), but this is not necessary because in larger hydrocarbon molecules, distant double bonds can form the necessary spatial arrangement for the cycloaddition (e.g.. Diels- Alder reaction of a 1,7-diene).

[0026] For example, in a particular embodiment, beta-pinene is first isomerized to a cyclohexadiene, which then undergoes Diels-Alder cycloaddition to form diunsaturated fused bicyclic products, for example, as follows:

[0027] Limonene undergoes a similar Diels-Alder cycloaddition, which follows limonene isomerization, and the products may themselves undergo acid-catalyzed isomerization to migrate the double bond of the product:

[0028] As with the ene reaction, the product hydrocarbons from the Diels-Alder reaction are themselves olefins, and they may further participate in mixed Diels-Alder condensations with the excess diene starting material to form trimers, tetramers, etc., of the isomerized terpene derivative.

[0029] In some embodiments, the acid-catalyst for the ene reaction or the Diels-Alder reaction is an Amberlyst-type solid resin (e.g., macroreticular or cellular resin or a functionalized silica resin with covalently bonded sulfonic acid or carboxylic acid groups). In other embodiments, the acid-catalyst may be a zeolite.

[0030] In some embodiments, the initial product of the ene reaction or Diels- Alder reaction is partially or fully hydrogenated to reduce one or more double bonds to single bonds, such as under catalytic hydrogenation conditions (e.g., hydrogen gas over a platinum or palladium catalyst). For example, the initial products from beta-pinene shown in the exemplary embodiments above may be hydrogenated as follows to form fully saturated hydrocarbons:HydrogenationSaturated ProductSaturated Product

[0031] All of the initial unsaturated limonene products can be similarly hydrogenated, for example:

[0032] In some embodiments, the above saturated products may be further hydrogenated to form ring-opened hydrocarbon derivatives, such as shown below:Initial dimer Saturated dimer Ring-opened dimer

[0033] The resulting hydrocarbon compounds, both saturated and unsaturated, promise to be sustainable ingredients useful for cosmetic, pharmaceutical, and personal care formulations. For example, the resulting cyclic compounds (unsaturated, saturated, or mixtures thereof) can be used in cosmetics ‘as-is’ or in combination with other ingredients for sustainable and biodegradable end-user applications (e.g. as emollients, green solvents, perfume ingredients, additives, or agriculture actives, such as insect pheromones). These targeted products will have applications, not only in cosmetic and material sciences (e.g. performance liquid polymers, silicone replacement, fluoropolymer replacements and performance lubricant) but also in biofuels, and high-energy and high-density fuels (e.g., rocket propellants, renewable transportation fuels, alternatives for aviation and aerospace fuels, such as JP-10 and RJ-5).

[0034] In some embodiments, the hydrocarbon compounds disclosed herein have an exceptionally high refractive index, making them ideal for high shine applications (e.g., hair, skin, lip formulations. In some embodiments, the hydrocarbon compounds disclosed herein have a high surface tension for the given viscosity, giving them structure and the ability to form a hydrophobic barrier. This is excellent for lip care and for creating water proofing for long wear cosmetics and / or sun care products. In some embodiments, the hydrocarbon compounds disclosed herein burn cleaner than traditional linear Cl 0-40 alkanes, such as in candle compositions. Without being bound by theory, it is believed that this is due to their highly-branched, energy-dense architecture. In some embodiments, the hydrocarbon compounds disclosed herein solubilize organic sun filters (e.g., avobenzone, octocrylene, oxybenzone) better than traditional linear Cl 0-40 alkanes. In some embodiments, the hydrocarbon compounds disclosed herein can be used as a film former (e.g., C30 and above oligomers).

[0035] In another aspect, the present disclosure provides a method for making a terpene oligomer hydrocarbon (e.g., C10-C40) comprising the steps of (a) exposing a terpene (e.g., a mono-terpene) to an acid catalyst (e.g., a solid-phase acid catalyst), for a sufficient period of time to form one or more oligomers of the terpene (e.g., dimer, trimer, tetramer, etc.) by the ene-reaction or the Diels-Alder reaction, and (b) purifying or isolating one or more products, and optionally (c) hydrogenating one or more of the products (or a mixture thereof) to form one or more hydrogenated products. In some embodiments, the method further comprises a preceding step of exposing a terpene (e.g., a bicyclic monounsaturated mono-terpene) to an acid-catalyst (e.g., a solid-phase acid catalyst), for a sufficient period of time to form one or more dieneisomers of the terpene (e.g., a monocyclic diunsaturated mono-terpene derivative), which derivative is suitable for the Diels-Alder reaction of step (a).

[0036] In another aspect, the present disclosure provides methods of using, and uses of. the compound of the present disclosure, such as use in cosmetic products, pharmaceutical products, personal care products, and for other industrial uses. The compounds may be particularly suitable as flavor ingredients, insect attractants, plasticizers, pesticides, disinfectants, perfumes, fragrances, varnish resins, fragrance additives, polymerization accelerators (e.g., for rubber), textile auxiliaries, flotation aids, cleaning products, traction fluids, melt adhesives, lubricating oil additives, fuel additives, and oil field chemicals.

[0037] In a further aspect, the present disclosure provides cosmetic and personal care compositions comprising the compounds of the disclosure. The compounds disclosed herein can be formulated without water, so they can be used in waterless, water-free, and anhydrous cosmetics. Therefore, this will reduce their water footprint and decrease the carbon footprint of the supply chain.DETAILED DESCRIPTION

[0038] The term terpene refers to natural or semisynthetic hydrocarbon terpenes having at least one double bond, including but not limited to, monoterpenes, such as monocyclic monoterpenes (e.g., limonene) or bicyclic monoterpenes (e.g., alpha-pinene, beta-pinene, camphene, sabinene, carene, or thujone), diterpenes, and triterpenes. As used herein, the term also includes terpene precursor or precursor equivalents, such as isoprene, cyclopentadiene, and isobutylene.

[0039] The term terpene “oligomer,” including the embraced terms terpene “dimer,” “trimer,” “tetramer,” and the like, refer to the bridged products formed, or formable, from a terpene via an ene- self-coupling reaction, and the fused products formed, or formable, from a terpene, or an isomerized derivative thereof (e.g., diene derivatives thereof), via a Diels-Alder self-coupling reaction. The present disclosure is directed to these oligomer compounds per se, although some may be possible to synthesize using alternative and entirely different synthetic means. Nevertheless, the skilled organic chemist would be readily able to determine the structures of the terpene oligomer hydrocarbons which could be made using the ene coupling chemistry and Diels-Alder cycloaddition chemistry described herein. Unless clearly stated otherwise, the embodiments of the present disclosure are not to be construed as product-by-process embodiments. Tt is further understood that since monoterpenes are CIO hydrocarbons, the dimers, trimers, and tetramers of monoterpenes provided herein are C20, C30, and C40 hydrocarbons, respectively, and so on for higher oligomers (e.g., pentamers are C50 hydrocarbons, etc.). A corresponding understanding applies to oligomers of sesquiterpenes, diterpenes and higher terpenes.

[0040] In a first aspect, the present disclosure therefore provides a hydrocarbon compound (Compound 1), wherein the hydrocarbon compound is a terpene oligomer (e.g., C10-C40), derived from, or derivable from, a terpene (e.g., a monocyclic or bicyclic monoterpene) via ene reaction coupling of said terpene, or via Diels-Alder cycloaddition of said terpene, or via Diels-Alder cycloaddition of a diene isomer of said terpene; or partially or fully saturated derivative thereof.

[0041] In further embodiments of the first aspect, the disclosure provides any of the following:1.1 Compound 1, wherein the compound is derived from, or derivable from, a terpene (e.g.. a monocyclic or bicyclic monoterpene) via ene reaction coupling of said terpene;1.2 Compound 1, wherein the compound is derived from, or derivable from, a terpene (e.g., a diunsaturated monocyclic or bicyclic monoterpene) via Diels-Alder cycloaddition of said terpene;1.3 Compound 1, wherein the compound is derived from, or derivable from, a terpene (e.g.. a monounsaturated bicyclic monoterpene) via isomerization of the terpene to a form a diunsaturated terpene derivative (e.g., a diunsaturated monocyclic monoterpene), followed by Diels-Alder cycloaddition of said diunsaturated terpene derivative;1.4 Compound 1, or any of 1.1-1.3, wherein said terpene is a monoterpene (CIO hydrocarbon);1.5 Compound 1, or any of 1.1-1.3, wherein said terpene is a sesquiterpene (C15 hydrocarbon);1.6 Compound 1, or any of 1.1-1.3, wherein said terpene is a diterpene (C20 hydrocarbon), or a higher terpene;1.7 Compound 1, or any of 1.1 -1.6, wherein said terpene is a monocyclic terpene;1.8 Compound 1, or any of 1.1-1.6, wherein said terpene is a bicyclic terpene (e.g., fused bicyclic and / or bridged bicyclic);1.9 Compound 1 , or any of 1.1 - 1.6, wherein said terpene is a tricyclic terpene or higher-polycyclic terpene (e.g., a total of 4, 5, 6, 7, or 8 rings);1.10 Compound 1, or any of 1.1 -1.6, wherein said terpene is an acyclic terpene;1.11 Compound 1 , or any of 1.1 - 1.10, wherein said terpene is a monounsaturated terpene; 1.12 Compound 1, or any of 1.1-1.10, wherein said terpene is a diunsaturated terpene (e.g., 1,3-diene or a 1,7-diene);1.13 Compound 1, or any of 1.1-1.12, wherein said terpene is isomerized (or isomerizable) to form a diunsaturated terpene derivative (e.g., a diunsaturated monocyclic monoterpene);1.14 Compound 1.13, wherein said terpene is a monoun saturated bicyclic terpene and said diunsaturated terpene derivative is a diunsaturated monocyclic terpene;1.15 Compound 1.14, wherein said terpene is a monounsaturated bicyclic monoterpene and said diunsaturated terpene derivative is a diunsaturated monocyclic monoterpene;1.16 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, 3-carene, alpha-thujene, beta-thujene, alpha-terpinene, beta-terpinene, gamma-terpinene, terpinolene, alpha-phellandrene, beta-phellandrene, gamma-murolene, longifolene, delta-cadinene, humulene, caryophyllene, taxadiene, curcumene, germacrene, and laurene;1.17 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene. 3-carene, alpha-thujene, beta-thujene, alpha-terpinene, beta-terpinene, gamma-terpinene, terpinolene, alpha-phellandrene, and beta-phellandrene;1.18 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, 3-carene, alpha-thujene, and beta-thujene;1.19 Compound 1 , or any of 1.1 - 1.15. wherein said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, and 3-carene;1.20 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, and camphene;1.21 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of beta-pinene and limonene;1.22 Compound 1, or any of 1.1-1.15, wherein said terpene is beta-pinene;1.23 Compound 1, or any of 1.1-1.15, wherein said terpene is limonene;1.24 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of isoprene, myrcene (beta-myrcene), alpha-myrcene, farnesene. ocimene, squalene, beta-bisabolene, alpha- zingiberene, seslinene, valencene, thuj opsene, aromadederene, and camberene;1.25 Compound 1, or any of 1.1-1.15. wherein said terpene is a terpene precursor or equivalent, e.g., isoprene, cyclopentadiene, or isobutylene;1.26 Compound 1, or any of 1.1-1.15, wherein said terpene is selected from the group consisting of:1.27 Compound 1 , or any of 1.1 - 1.25, wherein the terpene oligomer hydrocarbon compound is a terpene dimer (e.g., a CIO hydrocarbon if derived from 5-carbon terpene precursor; a C20 hydrocarbon if derived from a monoterpene: a C30 hydrocarbon if derived from a sesquiterpene; a C40 hydrocarbon if derived from a diterpene, etc.), optionally wherein the terpene is betapinene or limonene;1.28 Compound 1, or any of 1.1-1.25. wherein the terpene oligomer hydrocarbon compound is a terpene trimer (e.g., a C15 hydrocarbon if derived from 5-carbon terpene precursor; a C30 hydrocarbon if derived from a monoterpene; a C45 hydrocarbon if derived from a sesquiterpene, etc.), optionally wherein the terpene is beta-pinene or limonene;1.29 Compound 1, or any of 1.1-1.25, wherein the terpene oligomer hydrocarbon compound is a terpene tetramer (e.g., a C20 hydrocarbon if derived from 5-carbon terpene precursor; a C40 hydrocarbon if derived from a monoterpene; etc.), optionally wherein the terpene is beta-pinene or limonene;1.30 Compound 1, or any of 1.1-1.29. wherein the terpene oligomer hydrocarbon is a mixture of said dimer, trimer, or tetramer, optionally wherein the terpene is beta-pinene or limonene; 1.31 Compound 1.30, wherein the terpene oligomer hydrocarbon consists of, or consists essentially of a terpene dimer, terpene trimer, and / or terpene tetramer (e.g., in a net amount of at least 95% by weight, or at least 98% by weight, or at least 99% by weight), optionally wherein the terpene is beta-pinene or limonene;1.32 Compound 1.30 or 1.31, wherein the terpene oligomer hydrocarbon consists of, or consists essentially of at least 50% by weight of terpene dimer and less than 50% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;1.33 Compound 1.30 or 1.31, wherein the terpene oligomer hydrocarbon consists of, or consists essentially of at least 70% by weight of terpene dimer and less than 30% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;1.34 Compound 1.30 or 1.31, wherein the terpene oligomer hydrocarbon consists of, or consists essentially of at least 80% by weight of terpene dimer and less than 20% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;1.35 Compound 1.30 or 1.31 , wherein the terpene oligomer hydrocarbon consists of, or consists essentially of at least 90% by weight of terpene dimer and less than 10% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;1.36 Compound 1, or any of 1.1-1.35, wherein the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:ppp ? ■ '■ pXc IJPrPYpyp^ ^xpPPtX pP^YyA y / jf Xx Pt® Ppp XkQt3 ^'''^ XXXx -K';^CC -OLGxX xp^ X D XIXJp V?\ / xX XX-O XX XXpT X )x> (J"PYx ' T "'><( A I xP / XX> / y \pxXL YA YA II■00o . oxXV1.37 Compound 1, or any of 1.1-1.36, wherein the terpene oligomer hydrocarbon is (or comprises) a partially or fully saturated derivative of the terpene oligomer hydrocarbon according to any one of embodiments 1.1-1.36, optionally wherein the terpene is beta-pinene or limonene;1.38 Compound 1.37, wherein the partially or fully saturated derivative is characterized by having one, two, or three fewer double bonds than the terpene oligomer hydrocarbon according to any one of embodiments 1.1-1.36, optionally wherein the terpene is beta-pinene or limonene; 1.39 Compound 1.37 or 1.38, wherein the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:X^Xlyy 'X^x^,^xxXxp J^y-xjjO^ ^ iXXXx^tzx^ CX^XjX^ ^XX^JX ^XXXX xXXxO 0^^^xx^^XxC^ cx^^^XX?^ otx^E^X^xy ^XJ>^^XX^y<y^CD^vI^—1.40 Compound 1, or any of 1.1-1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:, or mixtures thereof; 1.41 Compound 1, or any of 1.1-1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:1.42 Compound 1 , or any of 1.1 - 1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:mixtures thereof:1.43 Compound 1, or any of 1.1-1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon comprises the following compound:, in admixture with at least one other compound selected from the groupwherein the mixture comprises at least 70% by weightof and at least 1% by weight but less than 30% by weight of any one or more of the other stated compounds;1.44 Compound 1, or any of 1.1-1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:or mixtures thereof; 1.45 Compound 1, or any of 1.1-1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is, or comprises, a beta-pinene dimer selected from the group consisting of:, or a trimer or tetramer derivative of any of the foregoing, or mixtures thereof;1.46 Compound 1, or any of 1.1-1.39, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is, or comprises, a hydrogenated beta-pinene dimer selected from the group consisting of:trimer or tetramer derivative of any of the foregoing, or mixtures thereof;1.47 Compound 1 , or any of 1.1 - 1.39, wherein the terpene is alpha-pinene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:thereof, wherein n is an integer from 0-3 in each of said structures;1.48 Compound 1, or any of 1.1-1.39, wherein the terpene is 3-carene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:mixtures thereof, wherein n is an integer from 0-3 in each of said structures;1.49 Compound 1, or any of 1.1-1.39, wherein the terpene is camphene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:, and , or mixtures thereof, wherein n is an integer from 0-3 in each of said structures;1.50 Compound 1, or any of 1.1-1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is, or comprises, a limonene dimer selected from the group consisting of:mixtures thereof;1.51 Compound 1, or any of 1.1-1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is, or comprises, a hydrogenated limonene dimer selected from the group consisting of:, or a trimer or tetramer derivative of any of the foregoing, or mixtures thereof; 1.52 Compound 1, or any of 1.1-1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:1.53 Compound 1 , or any of 1.1 - 1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:, or mixtures thereof;1.54 Compound 1, or any of 1.1-1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:1.55 Compound 1, or any of 1.1-1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:, or mixtures thereof;1.56 Compound 1, or any of 1.1-1.39, wherein the terpene is limonene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:mixtures thereof;1.57 Compound 1, or any of 1.1-1.39. wherein the terpene is limonene and the terpene oligomer hydrocarbon comprises at least one or two or three or four of the following compounds:compound selected from the group consisting of:, optionally wherein the mixture comprises at least 70% by weightof the combination ofand at least 1% by weight but less than 30% by weight of any one or more of the other stated compounds;1.58 Any preceding compound, wherein the compound is in admixture with at least one other foregoing compound, for example, a terpene dimer with the corresponding trimer or tetramerderived or derivable from the same terpene, or a terpene oligomer with the corresponding partially or fully saturated or ring-opened hydrogenation derivative;1.59 Compound 1, or any of 1.1-1.58, wherein the terpene is beta-pinene or limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of dimer, trimer and tetramer product (e.g., greater than 75% dimer, and 20-25% of trimer and tetramer (e.g., < 5% all other oligomers)), optionally wherein the product is fully hydrogenated;1.60 Compound 1, or any of 1.1-1.58, the terpene is beta-pinene or limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of dimer, trimer and tetramer product (e.g., greater than 85% dimer, and 12-15% of trimer and tetramer (e.g., < 3% all other oligomers)) , optionally wherein the product is fully hydrogenated;1.61 Compound 1, or any of 1.1-1.58, wherein the terpene is beta-pinene or limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of dimer, trimer and tetramer product (e.g., greater than 90% dimer, and 8-10% of trimer and tetramer (e.g., < 2% all other oligomers)) , optionally wherein the product is fully hydrogenated;1.62 Compound 1, or any of 1.1-1.56, wherein the terpene is beta-pinene or limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of 70-85% dimer, 12-20% trimer, 2-5% tetramer, and < 2% all other oligomers, each fully hydrogenated;1.63 Compound 1, or any of 1.1-1.58, wherein the terpene is beta-pinene or limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of 80-85% dimer, 12-15% trimer, 2-3% tetramer, and < 2% all other oligomers, each fully hydrogenated, optionally wherein the terpene is beta-pinene;1.64 Compound 1, or any of 1.1-1.58, wherein the terpene is beta-pinene or limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of 70-75% dimer, 15-18% trimer, 4-5% tetramer, and < 2% all other oligomers, each fully hydrogenated, optionally wherein the terpene is limonene;1.65 Compound 1, or any of 1.1-1.58, wherein the terpene is beta-pinene, and the terpene oligomer hydrocarbon comprises, or consists essentially of about 83% dimer, about 14% trimer, about 2.5% tetramer, and < 1.5% all other oligomers, each fully hydrogenated;1.66 Compound 1, or any of 1.1-1.58, wherein the terpene is limonene, and the terpene oligomer hydrocarbon comprises, or consists essentially of about 75% dimer, about 19% trimer, about 5% tetramer, and < 2% all other oligomers, each fully hydrogenated;1.67 Compound 1, or any of 1.1-1.66, wherein the limonene is (S)-limonene;1.68 Compound 1, or any of 1.1-1.66, wherein the limonene is (R)-limonene;1.69 Compound 1, or any of 1.1-1.68, wherein the terpene is not beta-pinene and / or wherein the terpene oligomer hydrocarbon is not, or does not comprise:1.70 Compound 1, or any of 1.1-1.69, wherein the terpene is not alpha-pinene and / or the terpene oligomer hydrocarbon is not, or does not comprise:1.71 Compound 1, or any of 1.1-1.70, wherein the terpene is not alpha-terpinene and / or the terpene oligomer hydrocarbon is not. or does not comprise:or1.72 Compound 1, or any of 1.1-1.71, wherein the compound has a refractive index of greater than 1.5, e.g., 1.5 to 1.8, or 1.5 to 1.7, or 1.5 to 1.6, or 1.5 to 1.55, or about 1.5:1.73 Compound 1, or any of 1.1-1.72, wherein the compound has a viscosity of 50 to 1000 cP (at 25 °C), e.g.. 50 to 750 cP, or 50 to 500 cP, or 50 to 400 cP, or 50 to 350 cP, or 50 to 250 cP, or 50 to 150 cP, or 100 to 600 cP, or 100 to 500 cP, or 100 to 400 cP, or 100 to 300 cP, or 100 to 200 cP, or about 155 cP;1.74 Compound 1, or any of 1.1-1.73, wherein the compound has a surface tension of 20 to 70 mN, e.g., 30 to 70 mN / m, or 30 to 60 mN / m, or 30 to 50 mN / m, or 30 to 40 mN / M, or 30-35 mN / m, or about 32 mN / m;1.75 Compound 1, or any of 1.1-1.74, wherein the compound solubilizes organic sun filters at a concentration of at least 5% by weight, e.g., 5 to 50% by weight, or 5 to 40% by weight, or 5 to 30% by weight, or 5 to 20% by weight, or 10 to 50% by weight, or 10 to 40% by weight, or 10 to30% by weight, or 10 to 20% by weight, or 20 to 50% by weight, or 20 to 40% by weight, or 20 to 30% by weight, 40 to 50% by weight;1.76 Compound 1.75. wherein the organic sun filters are selected from avobenzone, octocrylene, oxybenzone, octyl methoxycinnamate 2,4-dihydroxybenzophenone, 2, 2’, 4,4’-tetrahydroxybenzophenone, 4-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid or a salt thereof (e.g., sodium salt) or 2,2’-dihydroxy-4,4’-dimethoxybenzophenone-5,5’-bissulfonic acid or a salt thereof (e.g., monosodium or disodium salt), 2-ethylhexyl-4-methoxycinnamamate, butyl methoxydibenzoylmethane, bisethylhexyloxyphenol methoxyphenyl triazine, diethylamino hydroxybenzoyl hexyl benzoate, diethylhexyl butamido triazone, phenyl dibenzimidazole tetrasulfonic acid and salts thereof (e.g., disodium salt), 2-ethylhexyl 4-(dimethylamino)benzoate, 2-ethylhexyl 2-hydroxybenzoate, tris (2-ethylhexyl)-4,4',4"- ( 1 ,3 ,5 -triazine-2,4,6-triyltriimino)tribenzoate, 3,3,5-trimethylcyclohexyl salicylate, methylene bis-benzotriazolyl tetramethylbutylphenol, 2-ethylhexyl 2-cyano-3,3-diphenyl-2-acrylate. 2-phenyl-lH-benzimidazole-5-sulphonic acid and salts thereof (e.g., sodium salt), 2,4,6-tris(4-phenylphenyl)-l,3,5-triazine, l,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one, terephthalylidene dicamphor sulfonic acid and salts thereof (e.g., sodium salt), isoamyl p-methoxycinnamate, 2-(benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[methyl-bis(trimethylsilyloxy)silyl]propyl]phenol, ethyl 2-cyano-3,3-diphenylacrylate, 2 -hydroxy benzoic acid 2-butyloctyl ester.1.77 Compound 1.76, wherein the organic sun filters are selected from avobenzone, octocrylene, and oxybenzone;1.78 Any preceding compound, wherein the compound is made by a process as described in Method 1 or any of 1.1-1.106;

[0042] Preferably, the compounds disclosed herein are liquids at room temperature, and / or at temperatures above or below room temperature (e.g.., 10 to 30 °C).

[0043] The compounds disclosed herein (Compound 1, or any of 1.1 et seq., or any mixtures thereof) are suitable for use in cosmetic, pharmaceutical, and personal care compositions, including flavor and fragrance compositions, and as food additives. Their “solubility-viscosity characteristics” make them also useful as impregnants, adhesive materials, and as vehicles for metallic paints. The compounds are also compatible with many mineral oils and can be blendedwith rubber to produce soft tacky compositions. These compounds can also be used as perfume extenders, and broadly as adulterants as well as fixatives.

[0044] The compounds disclosed herein (Compound 1, or any of 1.1 et seq., or any mixtures thereof) can be used in a composition with one or more pharmaceutically acceptable, cosmetically acceptable or industrially acceptable excipients or carriers, for example, solvents, oils, surfactants, emollients, diluents, glidants, abrasives, humectants, plasticizers, catalysts, antioxidants, coloring agent, antibacterial agent, flavoring agent, fragrance agent, antiperspirant agent, antifungal agent, stabilizer or viscosity controlling agent.

[0045] The compounds disclosed herein (Compound 1, or any of 1.1 et seq., or any mixtures thereof) can be used alone or as a mixture with any cosmetically acceptable ingredients in a desired composition as flavor ingredients, insect attractant, plasticizer, pesticide, disinfectant, perfume fragrance, varnish resin, fragrance additive, polymerization accelerator for rubber, textile auxiliaries, flotation aids, cleaning products, traction fluids, melt adhesives, lubricating oil additives, fuel additives, and oil field chemicals

[0046] The compounds disclosed herein (Compound 1, or any of 1.1 et seq., or any mixtures thereof) can be used with polycitronellol, polycitronellol acetate or any citronellol-derived polymers to form new composition with modified or optimized viscosity, and other characteristics, for example, as an alternative to silicon-based commercial products.

[0047] The compounds disclosed herein (Compound 1, or any of 1.1 et seq., or any mixtures thereof) can also be used as solvents for a variety of chemical reactions including, but not limited to, hydrogenation, oxidation, reduction, polymerization, Diels-Alder reaction, dimerization, pericyclic reactions, ozonolysis, and others.

[0048] The compounds disclosed herein (Compound 1, or any of 1.1 et seq., or any mixtures thereof) may be formulated into various specialty chemical compositions or products, including personal care, hair care and skin care composition and products, in order to alter, modify and improve the function of such compositions or products. The functionality of the compound depends on its size and composition, and new and renewable compositions are highly desired as they have the potential to improve application performance.

[0049] In second aspect, the present disclosure provides a composition (Composition 1), which composition comprises Compound 1 or any of 1.1 et seq., or any mixtures thereof, in combination with at least one suitable solvent, carrier, or excipient, optionally wherein thecomposition is a cosmetic, pharmaceutical, or personal care composition. Tn further embodiments of the second aspect, the present disclosure provides Compositions as follows:1.1 A fragrance composition Compound 1 or any of 1.1 et seq., or any mixture thereof;1.2 A perfume composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.3 A soap composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof, e.g., a bar soap, a liquid soap, a body wash, a shampoo, a cosmetic remover, or a wipe;1.4 A pomander composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.5 A cosmetic composition comprising Compound 1 or any of 1.1 et seq, or any mixture thereof, such as, for example, a lipstick, lip balm, lip gloss, eye shadow, liquid highlighter (e.g., for the cheeks), a skin ointment, skin lotion, or a skin balm;1.6 A toilet water composition comprising Compound 1 or any of 1.1 et seq.. or any mixture thereof;1.7 A pre- and / or aftershave lotion composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.8 A talcum powder composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.9 A hair-care product composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof, for example, a hair styling product (e.g., hair spray, hair gel, or hair drying cream, mousse) or hair cleaning product (e.g.. shampoo or conditioner);1.10 A body deodorant composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.11 An anti-perspirant composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.12 A shampoo composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;1.13 A topically applied skin care composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof, optionally wherein the skin care application may be selected from skin-conditioning agents; skin penetration enhancing agents; skin protectants; skin soothingagents; skin healing agents; ultraviolet light absorbers or scattering agents; sequestrants; antiacne agents; anti-androgens; depilation agents; keratolytic agents / desquamation agents / exfoliants such as salicylic acid; panthenol moisturizer such as D-panthenol; soluble or colloidally-soluble moisturizing agents such as hyaluronic acid and starch-grafted sodium poly acrylates; and sunscreens;Composition 1.13. wherein the skin care application is a skin protectant;Composition 1.13, wherein the skin care application is a skin soothing agent or skin moisturizing agent (e.g., in a moisturizing lotion);Composition 1.13, wherein the skin care application is a sunscreen;An antimicrobial composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A mesogen comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A writing and / or printing ink composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A dye composition or pigment composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof, e.g., further comprising a dye and / or pigment;A paint or coating composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof, e.g., further comprising a dye and / or pigment;A skin-tone evening composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;An anti-hyperpigmentation composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;An anti-hypopigmentation composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A cross-linking, temporary stiffening, or permanent stiffening, composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof, e.g., in combination with a crosslinking agent, or a temporary or permanent stiffening agent;An insecticidal, insect repellant, or insect attractant composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A pesticide composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A plasticizer composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A cleaning product composition comprising Compound 1 or any of 1.1 et seq.. or any mixture thereof;A traction fluid composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A lubricating oil, lubricant, or friction-modifying composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;A fuel composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof; An oil field composition comprising Compound 1 or any of 1.1 et seq., or any mixture thereof;Composition 1, or any of 1.1-1.33, wherein the composition comprises, or consists of, Compound 1 or any of 1.1 et seq., dissolved or suspended in a solvent or mixture of solvents, e.g., ester, alkane, aromatic, alcohol, or ether solvents;Composition 1, or any of 1.1-1.33, wherein the composition is a solution or suspension of Compound 1 or any of 1.1 et seq., in a solvent or mixture of solvents, e.g., ester, alkane, aromatic, alcohol, or ether solvents;Composition 1.34 or 1.35, wherein the solvents are selected from Cl-4 esters (e.g., methyl acetate, ethyl acetate, isopropyl acetate). C4-18 esters, C3-10 alkanes (e.g., hexane, heptane, octane), C10-18 alkanes (linear or branched), C2-10 alcohols (e.g., ethanol, propanol, isopropanol), C2-10 ethers (e.g., diethyl ether, diisopropyl ether, methyl tert-butyl ether, tetrahydrofuran, dioxane), and C6-12 aromatics (e.g., toluene, xylenes);Composition 1, or any of 1.1-1.36, wherein the composition further comprises one or more natural oils;Composition 1, or any of 1.1-1.37. wherein the composition further comprises one or more alpha-hydroxy acids, beta-hydroxy acids, or salicylic acid;Composition 1, or any of 1.1-1.38, wherein the composition further comprises one or more synthetic layers double hydroxide clays;Composition 1, or any of 1.1-1.39, wherein the composition further comprises a mesoporous magnesium carbonate, e.g., Upsalite®;1.41 Composition 1, or any of 1.1-1.40, wherein the composition further comprises a keratolytic agent, e.g., salicylic acid, lactic acid, or urea;1.42 Composition 1, or any of 1.1-1.41, wherein the composition further comprises cannabidiol (CBD), tetrahydrocannabinol (THC), hemp oil, or hemp seed oil;1.43 Composition 1, or any of 1.1-1.42, wherein the composition further comprises one or more snow fungus extracts;1.44 Composition 1, or any of 1.1-1.43, wherein the composition further comprises Rosa canina fruit oil;1.45 Composition 1, or any of 1.1-1.44, wherein the composition is acid free, quat free, cruelty free, phosphate free, gluten free, paraben free, phthalate free, preservative free, nut free, peg free, formaldehyde free, sulfate free, and / or thiol free;1.46 Composition 1, or any of 1.1-1.45, wherein the composition further comprises any other cosmetically acceptable, pharmaceutically acceptable, or industrially acceptable excipients or carriers, for example, oils, surfactants, emollients, diluents, glidants, abrasives, humectants, plasticizers, catalysts, antioxidants, coloring agent, antibacterial agent, flavoring agent, fragrance agent, antiperspirant agent, antifungal agent, stabilizer or viscosity controlling agent;1.47 Composition 1, or any of 1.1-1.46, wherein the composition further comprises polycitronellol, polycitronellol acetate or any citronellol-derived polymers;1.48 Composition 1, or any of 1.1-1.47, wherein the composition further comprises triolein, 1,2-propanediol esters, ethylhexyl oxy stearate esters, or any combinations thereof; i.49Composition 1, or any of 1.1-1.47, wherein the composition (e.g., a cosmetic or sunscreen composition) further comprises an organic sun filter;1.50 Composition 1.49, wherein the organic sun filter is selected from avobenzone, octocrylene, oxybenzone, octyl methoxycinnamate 2,4-dihydroxybenzophenone, 2, 2’.4.4’- tetrahydroxybenzophenone, 4-hydroxy-4-methoxybenzophenone, 2-hydroxy-4- methoxybenzophenone-5 -sulfonic acid or a salt thereof (e.g., sodium salt) or 2,2’-dihydroxy- 4,4’-dimethoxybenzophenone-5,5’-bissulfonic acid or a salt thereof (e.g., monosodium or disodium salt), 2-ethylhexyl-4-methoxycinnamamate, butyl methoxydibenzoylmethane, bisethylhexyloxyphenol methoxyphenyl triazine, diethylamino hydroxybenzoyl hexyl benzoate, diethylhexyl butamido triazone, phenyl dibenzimidazole tetrasulfonic acid and salts thereof(e.g., disodium salt), 2-ethylhexyl 4-(dimethylamino)benzoate, 2-ethylhexyl 2- hydroxybenzoate, tris(2-ethylhexyl)-4,4',4"-(l,3,5-triazine-2,4,6-triyltriimino)tribenzoate, 3,3,5-trimethylcyclohexyl salicylate, methylene bis-benzotriazolyl tetramethylbutylphenol, 2- ethylhexyl 2-cyano-3,3-diphenyl-2-acrylate, 2-phenyl-lH-benzimidazole-5-sulphonic acid and salts thereof (e.g., sodium salt), 2,4,6-tris(4-phenylphenyl)-l,3,5-triazine, 1,7,7- trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one. terephthalylidene dicamphor sulfonic acid and salts thereof (e.g., sodium salt), isoamyl p-methoxycinnamate, 2-(benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[methyl- bis(trimethylsilyloxy)silyl]propyl]phenol, ethyl 2-cyano-3,3-diphenylacrylate, 2- hydroxybenzoic acid 2-butyloctyl ester, or a combination thereof;1.51 Composition 1.49, wherein the organic sun filter is selected from avobenzone, octocrylene, and oxybenzone, or a combination thereof;1.52 Composition 1.49, 1.50, or 1.51, wherein the composition comprises the sun filter(s) at a concentration of at least 5% by weight of the Compound 1 or any of 1.1 etseq., or any mixture thereof , e.g., 5 to 50% by weight, or 5 to 40% by weight, or 5 to 30% by weight, or 5 to 20% by weight, or 10 to 50% by weight, or 10 to 40% by weight, or 10 to 30% by weight, or 10 to 20% by weight, or 20 to 50% by weight, or 20 to 40% by weight, or 20 to 30% by weight, 40 to 50% by weight, each measured by weight of the Compound 1 or any of 1.1 etseq., or any mixture thereof;1.53 Any preceding composition, wherein the composition is an ethanol-free composition, e.g., an ethanol-free cosmetic composition;1.54 Any preceding composition, wherein the composition is packaged in a container or device comprising packaging made from high-density polyethylene (HDPE), low-density polyethylene (LDPE), polypropylene (PP) or high-density polypropylene (HDPP) or low- density polypropylene (LDPP), or polyethylene terephthalate (PET), or polystyrene (PS), or any combination thereof.

[0050] In another embodiment, the present disclosure provides Compound 1, or any of 1.1-1.78, for use in Composition 1, or any of 1.1-1.54.

[0051] Because the compounds disclosed herein are low-molecular weight hydrocarbons, they can be used as non-comedogenic additives for skin care and cosmetics, meaning that thecompounds will not potentially clog the pores of the applied surface areas when used such compositions and products.

[0052] The compounds disclosed herein can be used as or with an acid free, quat free, cruelty free, phosphate free, gluten free, paraben free, phthalate free, preservative free, nut free, peg free, formaldehyde free, sulfate free and thiol free formulations.

[0053] The compounds disclosed herein can be formulated without water, so they can be used in waterless, water-free, and anhydrous cosmetics. Therefore, this will reduce their water footprint and decrease the carbon footprint of the supply chain.

[0054] The compounds disclosed herein will be highly sustainable and eco-friendly. They will require minimal or no preservatives in their compositions. They will have small and less sophisticated packaging, and hence, will have better shelf life and last longer due to less dilution, compared to competitor products.

[0055] The compounds disclosed herein can be used with synthetic layered double hydroxide clays (LDHs) and can serve as rheology modifiers, mattifying agents, multifunctional excipients, absorbents and texturing agents in hair and skin care application. This combination can also be used in photoprotection and masking of bad odor and test and modified release.

[0056] The compounds disclosed herein can be used with Upsalite® (a mesoporous magnesium carbonate) in a variety of color cosmetic applications including hair and skin care.

[0057] The compounds disclosed herein can be used with CBD (cannabidiol), THC (tetrahydrocannabinol), hemp oil, and hemp seed oil to create formulated hair and skin-care products to calm post-workout redness, soothe irritation, and nourish dehydrated, stressed skin. In the above formulations, other natural ingredients can be present optionally, including red grape seed, pomegranate seed, broccoli, petitgrain, bergamot, cranberry, and lemon balm.

[0058] The compounds disclosed herein can be used as a lubricant or friction modifier composition for lubricants. The compounds disclosed herein can be used as additives to provide antioxidants, antifatigue, anti-wear, and deposit control properties to lubricants.

[0059] The compounds disclosed herein are nature derived and made from renewable resources, can be used with exosomes, neurocosmetics, and supercharged actives for personalized skincare.

[0060] The compounds disclosed herein can be used as an alternative for volatile silicones in skin and hair care applications. The volatility and fast spreadability might support creating dry, smooth textures for leave-on cosmetics.

[0061] The compounds described herein can be used in the composition of a traction fluid which optionally might include pour point depressants, viscosity index improvers, antioxidants, corrosion inhibitors, extreme pressure agents, anti-wear agents and anti-foam agents. A traction fluid that are non-toxic to humans and possess a non-offensive odor, while also being inexpensive to manufacture is desirable.

[0062] The compounds disclosed herein can generally be used in the following applications: sun protection and after-sun treatment, antiperspirant / deodorant, baby care and cleaning, body care (e.g., body wash, color care, face care, hair care, personal care, including personal care wipes), and self-tanning.

[0063] In third aspect, the present disclosure provides a method (Method 1) for making a terpene oligomer hydrocarbon (e.g., C10-C40) comprising the steps of (a) exposing a terpene (e.g., a mono-terpene) to an acid catalyst (e.g., a solid-phase acid catalyst), for a sufficient period of time to form one or more oligomers of the terpene (e.g., dimer, trimer, tetramer, etc.) by the ene-reaction or the Diels-Alder reaction, and (b) purifying or isolating one or more products, and optionally (c) hydrogenating one or more of the products (or a mixture thereof) to form one or more hydrogenated products. In some embodiments, the method further comprising a preceding step of exposing a terpene (e.g., a bicyclic monounsaturated mono-terpene) to an acid-catalyst (e.g., a solid-phase acid catalyst), for a sufficient period of time to form one or more diene isomers of the terpene (e.g.. a monocyclic diunsaturated mono-terpene derivative), which derivative is suitable for the Diels-Alder reaction of step (a). In further embodiments, Method 1 provides:1.1 Method 1, wherein step (a) is an ene-coupling reaction step;1.2 Method 1, wherein step (a) is a Diels-Alder cycloaddition reaction step;1.3 Method 1, 1.1, or 1.2, wherein the acid catalyst is a solid-phase acid catalyst, such as a resin-bound acid catalyst, an acidic clay (e.g., a Montmorillonite clay such as K10, or a Japanese acid clay), molecular sieves, or a zeolite;1.4 Method 1.3, wherein the acid catalyst is a resin-bound acid catalyst (e.g., a cation exchange resin);Method 1.4, wherein the acid catalyst is a macroreticular or cellular resin or a functionalized silica resin with covalently bonded sulfonic acid or carboxylic acid groups (e.g., an Amberlyst-type resin);Method 1, 1.1, or 1.2, wherein the acid-catalyst is a non-resin, solid acid catalyst, or a liquid acid catalyst;Method 1.6, wherein the acid catalyst is selected from formic acid, acetic acid, sulfuric acid, phosphoric acid, hydrofluoric acid, silica, copper chromite, and Lewis acids, e.g., boron trifluoride, aluminum chloride, stannous chloride, zirconium agents (e.g., zirconium phosphate), and titanium agents (e.g., titanium phosphates);Method 1, or any of 1.1-1.7, wherein step (a) comprises a solvent, e.g., water and / or an organic solvent or co-solvent (e.g., methanol, ethanol, isopropanol, propanol, tetrahydrofuran, acetonitrile, methyl acetate, ethyl acetate, isopropyl acetate, dichloromethane, chloroform, carbon tetrachloride, or toluene);Method 1, or any of 1.1 -1.7, wherein step (a) is conducted under neat, solvent-free conditions;Method 1, or any of 1.1- 1.9, wherein step (a) is conducted in a batch reactor, semi-batch reactor, or continuous packed bed-type reactor (e.g., a flow reactor), preferably wherein the step is conducted in a flow reactor;Method 1, or any of 1.1-1.10. wherein step (a) is conducted at a temperature from 20 °C to 150 °C, e.g., 30 °C to 130 °C, or 50 °C to 120 °C, or 80 °C to 110 °C, or 90 °C to 105 °C or about 90 °C;Method 1, or any of 1.1-1.11. wherein step (a) is conducted by passing the neat terpene (or terpene derivative) through a stainless- steel tube (e.g., 0.1-1-inch diameter) packed with Amberlyst-type resin acid catalyst at a temperature of 80 °C to 110 °C (e.g., 90 °C to 105 °C. or about 90 °C), at a suitable flow rate (e.g., 0.5 to 10 mL / min, e.g., about 2 mL / min);Method 1 or any of 1.1-1.12, wherein the step (b) comprises a filtration, extraction, or distillation step to purify one or more products from the reaction of step (a);Method 1.13, wherein step (b) removes terpene starting materials and / or by-products from the terpene oligomer product of step (a);Method 1.13 or 1.14, wherein step (b) separates or isolates one or more terpene oligomers, partially or completely, e.g., wherein step (b) provides separated or substantially separated dimer, trimer, and / or tetramer products, or wherein step (b) provides a mixture of dimer, trimer and / or tetramer products of selected composition (e.g., adjusted by altering distillation conditions);Method 1, or any of 1.1-1.12, wherein step (c) follows step (a) without purification of the product stream from step (a);Method 1 or any of 1.1-1.16, wherein the method further comprises the step (c) of hydrogenating the terpene oligomer, or a mixture of terpene oligomers, to form one or more hydrogenated products;Method 1.17, wherein the hydrogenation is performed using hydrogen gas and a transition metal catalyst, for example, a homogenous or heterogenous catalyst, e.g., comprising a palladium, platinum, nickel, iridium, rhodium, or ruthenium compound; Method 1.18, wherein the hydrogenation catalyst is platinum, platinum oxide, palladium on carbon (Pd / C), palladium hydroxide, or palladium oxide;Method 1.18 or 1.19, wherein the hydrogenation is conducted at a pressure of 1 to 50 atmosphere, e.g., 1-40 atmospheres, 1-30 atmospheres, 1-20 atmospheres, 1-10 atmospheres, 1-5 atmospheres, 1-3 atmospheres, 3-6 atmospheres, 6-10 atmospheres, 10-20 atmospheres, 20-50 atmospheres, 20-30 atmospheres, 30-40 atmospheres. 35 to 40 atmospheres, or about 38 atmospheres;Method 1.18, 1.19, or 1.20, wherein the hydrogenation is conducted at a temperature from 20 °C to 100 °C, e.g., 20 °C to 80 °C. or 20 °C to 70 °C. or 20 °C to 60 °C. or 30 °C to 90 °C, or 40 °C to 80 °C, or 50 °C to 70 °C, or 50 °C to 60 °C, or about 55 °C;Method 1.17, wherein the hydrogenation catalyst is palladium on carbon (Pd / C), and wherein the hydrogenation is conducted at a pressure of 20-50 atmospheres, 20-30 atmospheres, 30-40 atmospheres, 35 to 40 atmospheres, or about 38 atmospheres, and a temperature of 40 °C to 80 °C, or 50 °C to 70 °C, or 50 °C to 60 °C, or about 55 °C;Method 1.22, wherein the solvent for the hydrogenation is methanol, THF, or a mixture thereof;Method 1.17, wherein the hydrogenation is performed via transfer hydrogenation (e.g., using ammonium formate or another hydrogen donor);Method 1.17, wherein the hydrogenation is performed using catalytic transfer hydrogenation (CTH) using limonene as a dual-function hydrogen donor and solvent, with a transition metal catalyst (e.g., Pd / C);Any one of Methods 1.17-1.25, wherein the hydrogenation is performed in flow reactor, a continuously- stirred tank reactor (CSTR), a loop reactor, or a batch reactor, preferably wherein the hydrogenation is performed in a flow reactor;Any one of Methods 1.17-1.26, wherein the hydrogenation step provides products in which one or more double bonds in the product from step (a) or step (b) are reduced to single bonds, or wherein all of the double bonds in the product from step (a) or step (b) are reduced to single bonds ;Any one of Methods 1.17-1.27, wherein the hydrogenation step provides products in which one or more rings in the product from step (a) or step (b) are opened to form ring-opened products;Any one of Methods 1.17-1.28, wherein the hydrogenation step provides a mixture of unsaturated, partially unsaturated, fully saturated and / or ring-opened products;Any one of Methods 1.17-1.29, wherein the hydrogenation step (c) is followed by purification step (b);Method 1.30, wherein the step (b) following step (c) comprises a filtration, extraction, or distillation step to purify one or more products from the reaction of step (c);Method 1.31, wherein step (b) removes terpene starting materials and / or by-products from the hydrogenated terpene oligomer product of step (c);Method 1.31 or 1.32, wherein step (b) separates or isolates one or more hydrogenated terpene oligomers, partially or completely, e.g., wherein step (b) provides separated or substantially separated hydrogenated dimer, trimer, and / or tetramer products, or wherein step (b) provides a mixture of hydrogenated dimer, trimer and / or tetramer products, optionally in admixture with non-hydrogenated compounds from step (a);Method 1, or any of 1.1-1.33. wherein the method further comprises a step preceding step (a) wherein this in this step (e) a terpene (e.g., a bicyclic monounsaturated mono-terpene) is exposed to an acid-catalyst (e.g., a solid-phase acid catalyst), for a sufficient period of time to form one or more diene isomers of the terpene (e.g., a monocyclic diunsaturatedmono-terpene derivative), which derivative is suitable for the Diels- Alder reaction of step (a);Method 1.34, wherein the acid catalyst is a solid-phase acid catalyst, such as a resinbound acid catalyst, an acidic clay (e.g., a Montmorillonite clay such as K10, or a Japanese acid clay), molecular sieves, or a zeolite;Method 1.35, wherein the acid catalyst is a resin-bound acid catalyst (e.g., a cation exchange resin);Method 1.36, wherein the acid catalyst is a macro reticular or cellular resin or a functionalized silica resin with covalently bonded sulfonic acid or carboxylic acid groups (e.g., an Amberlyst-type resin);Method 1.34, 1.35, or 1.36, wherein the acid-catalyst is a non-resin, solid acid catalyst, or a liquid acid catalyst;Method 1.38, wherein the acid catalyst is selected from formic acid, acetic acid, sulfuric acid, phosphoric acid, hydrofluoric acid, silica, copper chromite, and Lewis acids, e.g., boron trifluoride, aluminum chloride, stannous chloride, zirconium agents (e.g., zirconium phosphate), and titanium agents (e.g., titanium phosphates);Any of Methods 1.34-1.39, wherein this preliminary step (e) comprises a solvent, e.g., water and / or an organic solvent or co-solvent (e.g., methanol, ethanol, isopropanol, propanol, tetrahydrofuran, acetonitrile, methyl acetate, ethyl acetate, isopropyl acetate, dichloromethane, chloroform, carbon tetrachloride, or toluene);Any of Methods 1.34-1.39, wherein the preliminary step (e) is conducted under neat, solvent- free conditions;Any of Methods 1.34-1.41, wherein preliminary step (e) is conducted in a batch reactor, semi-batch reactor, or continuous packed bed-type reactor (e.g., a flow reactor), preferably wherein the step is conducted in a flow reactor;Any of Methods 1.34-1.42, wherein preliminary step (e) is conducted at a temperature from 20 °C to 150 °C, e.g., 30 °C to 130 °C, or 50 °C to 120 °C, or 80 °C to 110 °C. or about 90 °C;Any of Methods 1.34-1.43, wherein preliminary step (e) is conducted by passing the neat terpene through a stainless-steel tube (e.g., 0.1-1-inch diameter) packed with Amberlyst-type resin acid catalyst at a temperature of 80 °C to 110 °C (e.g., about 90 °C), at a suitable flow rate (e.g., 0.5 to 10 mL / min, e.g., about 2 mL / min);Any of Methods 1.34-1.44, wherein preliminary step (e) is followed by a second preliminary step (f) which comprises a filtration, extraction, or distillation step to purify one or more products from the reaction of preliminary step (e);Method 1.45, wherein preliminary step (f) removes terpene starting materials and / or byproducts from the isomerized terpene derivative product of preliminary step (e);Any of Methods 1.34-1.44, wherein step (a) follows preliminary step (e) without purification of the product stream from preliminary step (e);Any of Methods 1.1-1.47, wherein the product of the method is a compound, or a mixture of compounds according to Compound 1, or any of 1.1-1.49;Any of Methods 1.1-1.48, wherein in step (a), said terpene is a monoterpene (CIO hydrocarbon);Any of Methods 1.1-1.49, wherein in step (a), said terpene is a sesquiterpene (C15 hydrocarbon);Any of Methods 1.1-1.49, wherein in step (a), said terpene is a diterpene (C20 hydrocarbon), or a higher terpene;Any of Methods 1.1-1.51, wherein in step (a), said terpene is a monocyclic terpene; Any of Methods 1.1-1.51, wherein in step (a), said terpene is a bicyclic terpene (e.g., fused bicyclic and / or bridged bicyclic);Any of Methods 1.1-1.51, wherein in step (a), said terpene is a tricyclic terpene or higher-polycyclic terpene (e.g.. a total of 4, 5. 6, 7, or 8 rings);Any of Methods 1.1-1.51, wherein in step (a), said terpene is an acyclic terpene;Any of Methods 1.1-1.55, wherein in step (a), said terpene is a monounsaturated terpene; Any of Methods 1.1-1.55, wherein in step (a), said terpene is a diunsaturated terpene (e.g., 1,3-diene ora 1,7-diene);Any of Methods 1.1-1.57, wherein in step (a), said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, 3-carene, alpha-thujene, beta-thujene, alpha-terpinene, beta-terpinene, gamma-terpinene, terpinolene, alpha-phellandrene, beta-phellandrene, gamma-murolene, longifolene, delta-cadinene, humulene, caryophyllene, taxadiene, curcumene, germacrene, and laurene;1.59 Any of Methods 1.1 -1.57, wherein in step (a), said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, 3-carene, alpha- thujene, beta-thujene, alpha-terpinene. beta-terpinene, gamma-terpinene, terpinolene, alpha-phellandrene, and beta-phellandrene;1.60 Any of Methods 1.1-1.57. wherein in step (a), said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, 3-carene, alpha- thujene, and beta-thujene;1.61 Any of Methods 1.1-1.57, wherein in step (a), said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, and 3-carene; 1.62 Any of Methods 1.1-1.57, wherein in step (a), said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, and camphene;1.63 Any of Methods 1.1-1.57, wherein in step (a), said terpene is selected from the group consisting of beta-pinene and limonene;1.64 Any of Methods 1.1-1.57, wherein in step (a), said terpene is beta-pinene;1.65 Any of Methods 1.1-1.57, wherein in step (a), said terpene is limonene;1.66 Any of Methods 1.1-1.57, wherein in step (a), said terpene is selected from the group consisting of isoprene, myrcene (beta-myrcene), alpha-myrcene, farnesene, ocimene, squalene, beta-bisabolene, alpha-zingiberene, seslinene, valencene, thujopsene, aromadederene, and camberene;1.67 Any of Methods 1.1-1.57, wherein in step (a), said terpene is a terpene precursor or equivalent, e.g., isoprene, cyclopentadiene, or isobutylene;1.79 Any of Methods 1.1-1.57, wherein in step (a), said terpene is selected from the group consisting of:■'V1 { jl)^j]Any of Methods 1.1-1.67, wherein in preliminary step (e), a terpene as described in any of Methods 1.46 to 1.62 is isomerized to form a diunsaturated terpene derivative (e.g., a diunsaturated monocyclic monoterpene) which terpene derivative is used in step (a); Method 1.68, wherein said terpene of used in preliminary step (e) is a monounsaturated bicyclic terpene and the product of preliminary step (e) is a diunsaturated monocyclic terpene;Method 1.69, wherein said terpene of used in preliminary step (e) is a monounsaturated bicyclic monoterpene and the product of preliminary step (e) is a diunsaturated monocyclic monoterpene;Method 1 , or any of 1.1 - 1.70, wherein the product of step (a) is, or comprises, a terpene dimer (e.g., a CIO hydrocarbon if derived from 5-carbon terpene precursor; a C20 hydrocarbon if derived from a monoterpene; a C30 hydrocarbon if derived from a sesquiterpene; a C40 hydrocarbon if derived from a diterpene, etc.), optionally wherein the terpene is beta-pinene or limonene;Method 1, or any of 1.1-1.70. wherein the product of step (a) is. or comprises, a terpene trimer (e.g., a C15 hydrocarbon if derived from 5-carbon terpene precursor; a C30 hydrocarbon if derived from a monoterpene; a C45 hydrocarbon if derived from a sesquiterpene, etc.), optionally wherein the terpene is beta-pinene or limonene;Method 1, or any of 1.1-1.70, wherein the product of step (a) is, or comprises, a terpene tetramer (e.g., a C20 hydrocarbon if derived from 5-carbon terpene precursor; a C40 hydrocarbon if derived from a monoterpene; etc.), optionally wherein the terpene is betapinene or limonene;Any of Methods 1.71-1.73, wherein the product of step (a) is, or comprises, a mixture of said terpene dimers, terpene trimers, and / or terpene tetramers, optionally wherein the terpene is beta-pinene or limonene;Method 1.74, wherein the product of step (a), or the product of step (b), is, or comprises, consists of, or consists essentially of a terpene dimer, terpene trimer, and / or terpene tetramer (e.g., in a net amount of at least 95% by weight, or at least 98% by weight, or at least 99% by weight), optionally wherein the terpene is beta-pinene or limonene;Method 1.74, wherein the product of step (a), or the product of step (b), is, or comprises, consists of. or consists essentially of at least 50% by weight of terpene dimer and less than 50% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;Method 1.74, wherein the product of step (a), or the product of step (b), is, or comprises, consists of, or consists essentially of at least 70% by weight of terpene dimer and less than 30% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;Method 1.74, wherein the product of step (a), or the product of step (b), is, or comprises, consists of. or consists essentially of at least 80% by weight of terpene dimer and lessthan 20% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;Method 1.74, wherein the product of step (a), or the product of step (b), is, or comprises, consists of, or consists essentially of at least 90% by weight of terpene dimer and less than 10% by weight of each of the terpene trimer, and / or terpene tetramer, optionally wherein the terpene is beta-pinene or limonene;Method 1, or any of 1.1-1.79, wherein the product of step (a), or the product of step (b), is. or comprises, a compound selected from the group consisting of:y} izp< APF J ' ' F tik / / / FJo:z. Art jy W <J ' >'Ar / :Ai PAAA H tAOF yTyvF ,. ” A: F p M Vo' I A QtFatF or A F 4 \ JAFAJO AA^A 4J1.IDGoIJJ AAA> AF 4VAY A11Aio A .AX;Kq^k A - yAX yOH__A<■yO^Jy"CX. cir. / :xx' / xcxMethod 1, or any of 1.1-1.79, wherein the product of step (c), is, or comprises, compounds characterized by having one, two. or three fewer double bonds than the compounds comprised in the product of step (a) or step (b), optionally wherein the terpene is beta-pinene or limonene;Method 1, or any of 1.1-1.79, wherein the product of step (c), is or comprises, a compound selected from the group consisting of:X^Xlyy 'X^x^,^xxXxp J^y-xjjO^ ^ iXXXx^tzx^ CX^XjX^ ^XX^JX ^XXXX xXXxO 0^^^xx^^XxC^ cx^^^XX?^ otx^E^X^xy ^XJ>^^XX^y<y^CD^vI^—Method 1, or any of 1.1-1.74, wherein the product of step (a) or step (b), is or comprises, a compound selected from the group consisting of:, or mixtures thereof;Method 1, or any of 1.1-1.79, wherein the product of step (c), is or comprises, a compound selected from the group consisting of:Method 1, or any of 1.1-1.79. wherein the product of step (c), is or comprises, a compound selected from the group consisting of:or mixtures thereof:Method 1, or any of 1.1-1.79. wherein the product of step (c), is or comprises, a mixturecomprising, and at least one other compound selected from the groupoptionally wherein the mixture comprises at least 70% by weightof and at least 1% by weight but less than 30% by weight of any one or more of the other stated compounds;1.86 Method 1 , or any of 1.1 - 1.79, wherein the product of step (a), is or comprises, a compound selected from the group consisting of:, or a mixture thereof;1.87 Method 1, or any of 1.1-1.79, wherein the product of step (c), is or comprises, a compound selected from the group consisting of:Method 1, or any of 1.1-1.79. wherein the product of step (a), (b). and / or (c). is or comprises, a beta-pinene dimer selected from the group consisting of, and , or a trimer or tetramer derivative of any of the foregoing, or mixtures thereof;1.89 Method 1, or any of 1.1-1.79. wherein the product of step (a), (b), and / or (c). is or comprises, a hydrogenated beta-pinene dimer selected from the group consisting of, and , or a trimer or tetramer derivative of any of the foregoing, or mixtures thereof;Method 1 , or any of 1.1 - 1.79, wherein the product of step (a), (b), and / or (c), is or comprises, a compound selected from the group consisting of:thereof, wherein n is an integer from 0-3 in each of said structures;Method 1, or any of 1.1-1.79. wherein the product of step (a), (b). and / or (c). is or comprises, a compound selected from the group consisting of:mixtures thereof, wherein n is an integer from 0-3 in each of said structures;Method 1, or any of 1.1-1.79. wherein the product of step (a), (b). and / or (c). is or comprises, a compound selected from the group consisting of:, or mixtures thereof, wherein n is an integer from 0-3 in each of said structures;Method 1, or any of 1.1-1.79. wherein the product of step (a), (b). and / or (c). is or comprises, a limonene dimer selected from the group consisting of:of the foregoing, or mixtures thereof;Method 1, or any of 1.1-1.79, wherein the product of step (a), (b), and / or (c), is or comprises, a limonene dimer selected from the group consisting of:, or a tnmer or tetramer derivative of any of the foregoing, or mixtures thereof;Method 1, or any of 1.1-1.79, wherein the product of step (a), (b), and / or (c), is or comprises, a compound selected from the group consisting of:Method 1 , or any of 1.1 - 1.79, wherein the product of step (a), (b), and / or (c), is or comprises, a compound selected from the group consisting of:Method 1, or any of 1.1-1.79. wherein the product of step (a), (b). and / or (c). is or comprises, a compound selected from the group consisting of:Method 1 , or any of 1.1 -1.79, wherein the product of step (a), (b), and / or (c), is or comprises, a compound selected from the group consisting of:, or mixtures thereof;Method 1, or any of 1.1-1.79, wherein the product of step (a), (b), and / or (c), is or comprises, a compound selected from the group consisting of:1.100 Method 1, or any of 1.1-1.79. wherein the product of step (a), (b), and / or (c). is or comprises, a compound selected from the group consisting of:in admixture with at least one other compound selected from the group consisting of:, optionally wherein the mixture comprises at least 70% by weight of the combination ofat least 1% by weight but less than 30% by weight of any one or more of the other stated compounds;1.101 Method 1, or any of 1.1-1.100, wherein the product of step (a), (b), and / or (c), is or comprises, a compound according to Compound 1, or any of 1.1-1.76, in admixture with at least one other foregoing compound, for example, a terpene dimer with the corresponding trimer or tetramer derived or derivable from the same terpene, or a terpene oligomer with the corresponding partially or fully saturated or ring-opened hydrogenation derivative.1.102 Method 1, or any of 1.1-1.101, wherein the terpene is not alpha-pinene;1.103 Method 1 , or any of 1.1 - 1.101 , wherein the terpene is not beta-pinene;1.104 Method 1, or any of 1.1-1.101, wherein the terpene is not alpha- terpinene;1.105 A compound (e.g., a terpene oligomer hydrocarbon) made according to any one of Methods 1 or 1.1-1.104;1.106 A mixture of compounds (e.g., a terpene oligomer hydrocarbon mixture), the mixture made according to any one of Methods 1 or 1.1-1.104, optionally wherein the terpene oligomer hydrocarbons are as described for Compound 1 or any of 1.1-1.78.

[0064] As used herein, the term “a trimer or tetramer derivative of any of the foregoing” will be understood to mean the trimer or tetramer products that are derived from any particular dimer by adding additional units of terpene of the same type that resulted in the dimer according to the same mechanism. Thus, for example, where the present disclosure refers, directly or indirectly, to the following product “or a trimer or tetramer derivative” thereof:the person of skill in the art would readily ascertain, in view of the present disclosure, that the above compound is an ene-coupling product of limonene which is derived from the following mechanism:It would thus be understood that extending that mechanism to provide a trimer by adding an additional molecule of limonene, would result in a trimer as follows:It is further understood that the additional reaction step to form the trimer may involved the same mechanism, but a different orientation or arrangement of starting molecules. All such possibilities are embraced by the term “a trimer or tetramer derivative of any of the foregoing” with respect to a particular dimer. It is further understood that when such term is used in connection with hydrogenated products, it refers to the hydrogenated trimers and tetramers that would be derived by hydrogenation of the unsaturated compounds provided above.

[0065] By altering the reaction conditions, some control can be exerted over the extent of the oligomerization reaction step (a), i.e., the ene reaction coupling or the Diels-Alder cycloaddition. For example, shorter reaction times, lower temperatures, and, if the reaction is done in a solvent, lower reactant concentrations, will tend to result in predominantly dimeric products, while longer reaction times, higher temperatures, and higher reactant concentrations, will increase the proportion of trimeric, tetrameric, and higher oligomeric products in the reaction. Optionally, the product from step (a), can be purified to any desired extent in step (b), such as by distillation, to provide a purer reactant stream for any subsequent hydrogenation step (c). Optionally, little or no purification is carried out before step (c), and instead, any purification according to the conditions described for step (b) is carried out after step (c). Thus, for example, the reaction of beta pinene under ene-coupling conditions can be summarized as follows:ene-couplingP-pineneP-pinene trimer p-pinene tetramer HydrogenationSaturated dimerSaturated tetramerHydrogenationRing opened tetramer

[0066] The skilled artisan will recognize that terpene starting materials for preliminary step (e) of Method 1 may undergo alternative isomerization reactions, and after the subsequent Diels-Alder cycloaddition and hydrogenation steps, different isomeric products can ultimately form.For example, beta-pinene can undergo isomerization to either an intracyclic 1,3-diene, or an exocyclic 1,3-diene, resulting in different final products:cycloadditionP-pineneI isomer 1 Product 1cycloadditionisomer 2Product 2

[0067] In another embodiment, the present disclosure provides a Compound made according to Method 1, or any of Methods 1.1-1.106 (e.g., a product made according to the process of Method 1, or any of 1.1-1.106).

[0068] In a fourth aspect the, the present disclosure provides a method of using Compound 1 et seq., e.g., produced by Method 1, et seq., in a composition (e.g., Composition 1, et seq., for example, a fragrance, perfume, soap, pomander, cosmetic, toilet water, pre- and aftershave lotion, talcum powder, hair-care product, body deodorant, anti-perspirant, shampoo, skin care product, pharmaceutical, or antimicrobial, as described in Composition 1, or any of Compositions 1.1-1.54).

[0069] Thus, the present disclosure provides a method of using Compound 1, or any of 1.1-1.78, in the manufacture of Composition 1, or any of Compositions 1.1-1.54.

[0070] In another aspect, the fragrance compositions of the present application, comprising the compounds of Compound 1, et seq., e.g., as produced by Method 1, et seq., and the fragrance composition is selected from: perfumes, soaps, pomanders, cosmetics, toilet waters, pre- and aftershave lotions, talcum powders, hair-care products, body deodorants, anti-per spirants, shampoo, cologne, shower gel, and hair spray.

[0071] The details of one or more embodiments of the invention are set forth in the accompanying description below. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In the case of conflict, the present specification will control.

[0072] Unless otherwise indicated, it is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. Inthis specification and in the claims that follow, reference will be made to a number of terms, which shall be defined to have the definitions set forth below.

[0073] As used herein, the following terms have the following meanings:(a) “Mesogen” means any polymeric compound or composition which displays liquid crystal properties (such as LCDs in consumer electronics);(b) “Cross-linking agent” means any polymeric compound or composition which enhances cotton’s dimensional stability, wrinkle resistance, and / or crease retention; (c) “Temporary or permanent stiffening agent” means any polymeric compound or composition which can be used in the process of cross-linking with fabric, such as, to play a crucial role in enhancing fabric properties, including making fabric more resilient and suitable for various end uses, particularly for cotton or linen; (d) “Skin-tone evening composition” means a composition which is applied to the skin to achieve a more uniform and balanced complexion, for example, any polymeric compound or composition which can be used for the purpose of “skin tone evening,” including to address irregularities such as hyperpigmentation, acne, scars, and redness;(e) “Super sensory” refers to the heightened sensory experience that a cosmetic product provides to the user including, but not limited to, feel, smell, and appearance;(f) “Exosomes” are microscopic extracellular vesicles produced within the body and secreted by skin cells, which can be used with any polymeric compound or composition in conjunction with in-office skin treatments or as part of a topical skincare regimen; exosomes have gained attention in the skincare industry due to their potential benefits including, but not limited to, anti-inflammatory properties, collagen boost, healing and rejuvenation, and environmental protection;(g) “Neurocosmetic” refers to certain beauty products designed, not only to protect and care for the skin, but also to enhance the user’s sense of well-being through the connection between the skin and the brain; neurocosmetic formulations incorporate specific compounds that create a multi-dimensional approach to skincare; (h) “Supercharged actives” refers to actives in a skin care composition enriched with the most potent ingredients to address or target the most universal skin concerns and / or deliver clinically tested visible results;(i) “Natural oils” generally refers to oils derived from plants, which can provide various benefits for the skin, and which are commonly used in cosmetic and skincare products due to their beneficial properties;(j) “Acid free” means free of, or low in (e.g., < 1 wt.%), alpha-hydroxy acids and / or beta-hydroxy acids;(k) “Quat free” means free of, or low in (e.g., < 1 wt.%), quaternary ammonium compounds, such as some cationic surfactants (e.g., benzalkonium);(l) “Cruelty free” means products or compositions that are not tested on animals, indicating avoidance of animal suffering and testing during product development; (m) “Phosphate free” means free of, or low in (e.g., < 1 wt.%), any phosphorus- containing compounds, including, but not limited to, inorganic orthophosphates, diphosphates (pyrophosphates), triphosphates, polyphosphates, phosphoric acid, and organic phosphates, phosphonates, phosphites, phosphines, phosphides, and other organophosphates;(n) “peg free” means free of, or low in (e.g., < 1 wt.%), polyethylene glycol) polymers; (o) “Sulfate free” means free of, or low in (e.g., < 1 wt.%), any oxo- sulfur-containing compounds including, but not limited to, inorganic sulfates, sulfites, and bisulfites, sulfuric acid, sulfurous acid, and organic sulfates, sulfonates, sulfites, and sulfinites, including, for example, sulfate or sulfonate surfactants (e.g.. sodium lauryl sulfate, sodium laureth sulfate);(p) “Thiol free” means free of, or low in (e.g., < 1 wt.%), any thiol-containing compounds, other than amino acids, polypeptides, and proteins, including, but not limited to, inorganic thiols or thiolates, and organic thiols and thiolates, as well as sulfide derivatives (dimers) thereof;(q) As used herein above, “free of. or low in” is intended to refer to added ingredients in compositions according to the present disclosure, as opposed to trace components which are the result of natural or artificial contamination, impurities, or natural products.

[0074] As used herein, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a reactant” includes not only a single reactant but also a combination or mixture of two or more different reactant,reference to “a substituent” includes a single substituent as well as two or more substituents, and the like.

[0075] As used herein, the phrases “for example,” “for instance,” “such as.” or “including” are meant to introduce examples that further clarify more general subject matter. These examples are provided only as an aid for understanding the disclosure, and are not meant to be limiting in any fashion. Furthermore, as used herein, the terms “may,” “optional.” “optionally,” or “may optionally” mean that the subsequently described circumstance may or may not occur, so that the description includes instances where the circumstance occurs and instances where it does not. For example, the phrase “optionally present” means that an object may or may not be present, and, thus, the description includes instances wherein the object is present and instances wherein the object is not present.

[0076] As used herein, the phrase “having the formula” or “having the structure” is not intended to be limiting and is used in the same way that the term “comprising” is commonly used.

[0077] In some formulae of the present application, one or more chiral centers are identified by an asterisk placed next to the chiral carbon. In other formulae, no chiral center is identified, but the chiral isomers are nonetheless covered by these formulae.

[0078] Some compounds of the present invention can exist in a tautomeric form which is also intended to be encompassed within the scope of the present invention.

[0079] “Tautomers” refers to compounds whose structures differ markedly in arrangement of atoms, but which exist in easy and rapid equilibrium. It is to be understood that the compounds of the invention may be depicted as different tautomers, it should also be understood that when compounds have tautomeric forms, ail tautomeric forms are intended to be within the scope of the invention, and the naming of the compounds does not exclude any tautomeric form. Further, even though one tautomer may be described, the present invention includes all tautomers of the present compounds.

[0080] As used herein, the term “fragrance composition” means a mixture of fragrance ingredients, including auxiliary substances if desired, dissolved in a suitable solvent or mixed with a powdery substrate used to provide a desired odor to a product.

[0081] Fragrance and ingredients and mixtures of fragrance ingredients that may be used in combination with the disclosed compound for the manufacture of fragrance compositionsinclude, but are not limited to, natural products including extracts, animal products and essential oils, absolutes, resinoids, resins, and concretes, and synthetic fragrance materials which include, but are not limited to, alcohols, aldehydes, ketones, ethers, acids, esters, acetals, phenols, ethers, lactones, furansketals, nitriles, acids, and hydrocarbons, including both saturated and unsaturated compounds and aliphatic carbocyclic and heterocyclic compounds, and animal products.

[0082] In the present specification, the structural formula of the compounds represents a certain isomer for convenience in some cases, but the present invention includes ail isomers, such as geometrical isomers, optical isomers based on an asymmetrical carbon, stereoisomers, tautomers, and the like. In addition, a crystal polymorphism may be present for the compounds represented by the formula, it is noted that any crystal form, crystal form mixture, or anhydride or hydrate thereof is included in the scope of the present invention.

[0083] All percentages used herein, unless otherwise indicated, are by volume.

[0084] All ratios used herein, unless otherwise indicated, are by molarity.EXAMPLES

[0085] Analytical Procedures: Molecular Weight Determination by GPC

[0086] Sample procedure: The sample is prepared by transferring 20-25 mg into a 10-mL volumetric flask, using unstabilized tetrahydrofuran (THF) as the diluent to bring the solution to volume and mixed vigorously.

[0087] Chromatographic Conditions: An isocratic chromatographic condition was used to separate the product peaks. The chromatographic parameters are listed below:Column: Agilent Oligopore GPC, 6pm, 7.5 x 300 mmDiluent: THF, inhibitor-free (unstabilized)Mobile Phase: THF, inhibitor- free(unstabilized)Flow Rate: 1.0 mL / minColumn Temperature: 25 + 2°CDetection: Refractive index (RID)Injection Volume: 30 pLRun Time: 25 minutes

[0088] GC Instrument: Agilent HPLC 1100 series with RI detector

[0089] GPC Analysis: A polystyrene standard is used to generate a linear equation to determine the molecular weight of each oligomer. The linear equation is generated based on the logMw vs. retention time (minute) of polystyrene standard as follows: y = -0.367 lx + 5.5885.Example 1. Synthesis of Beta-Pinene Oligomers

[0090] A 6-foot-long, 0.25-inch smooth bore stainless steel tube with a 0.01-inch wall thickness is packed with Amberlyst resin and is coiled and outfitted with PTFE tubing on either end for continuous flow. The coil is heated to a steady temperature between 90 °C and 105 °C in an oil bath, and 600 g of neat beta-pinene is pumped through the packed coil at a rate of 2 ml / min. Analysis is performed by gel-permeation chromatography (GPC) and gas chromatography (GC) as outlined above. The material coming out of the coil is found to have reached a high degree of dimerization (65%), with lesser degree of trimerization (13%) and tetramerization (4%) as shown by GPC and GC. All fractions are collected, and solid sodium carbonate (3 g) is added. The mixture is stirred for 5-10 minutes and then filtered. All of the low boiling fractions, including starting material, are removed from the product by distillation (temperature 90 °C, pressure 0.367 torr). The remaining distillate (268 g) is isolated as the product and characterized by GPC (Dimer: 82.6%, RT 9.14 minutes; Trimer: 13.7%, RT 8.63 minutes; Tetramer: 2.5%, RT 8.32 minutes; Pentamer: 1.2%, RT 8.04 minutes).

[0091] The structures of the product compounds are believed to comprise the following:(Dimer) (Trimer) (Tetramer) Example 2. Synthesis of (S)-(-)-Limonene Oligomers

[0092] The procedure of Example 1 is performed with 600 g of (S)-(-)-limonene. After the reaction and workup, the low boiling fractions ae distilled out (temperature 91 °C, pressure 0.919 torr). The remaining distillate (300 g) is isolated as the product and characterized by GPC (Dimer: 74.6%, RT 9.12 minutes; Trimer: 18.7%. RT 8.64 minutes; Tetramer: 4.8%, RT 8.33 minutes; Pentamer: 1.9%, RT 8.02 minutes).

[0093] The structures of the product dimer compounds are believed to comprise the following:

[0094] The structures of the product trimer compounds are believed to comprise, for example, the following, as well as trimer analogs of the other dimers shown above:

[0095] The structures of the product tetramer compounds are believed to comprise, for example, the following, as well as tetramer analogs of the other dimers shown above:Example 3. Hydrogenation of Oligomer Mixtures

[0096] 280 g of the distillate from Example 2 is combined with methanol (300 mL) and THF (300 mL), placed in an autoclave reactor, and charged with 10 g of 1% Pd / C (w / w). The mixture is placed under hydrogen at a pressure of 38 atmospheres at 50-60 °C for 16 hours. Themixture is filtered to remove the catalyst, and the filtrate is concentrated. Wiped film distillation (0.2-0.3 torr, 140 °C) is then performed, resulting in a distillate of 135.9 g. 'H-NMR shows that a significant amount of the alkane formed in the high field with a de minimus residue of the olefin at the low field. GC-FID shows that this distilled material is representative of C20 alkane product. The material is isolated as a nearly clear, flowing liquid.

[0097] The structures of the product compounds are believed to comprise the following:

[0098] The physical properties of the produced material are studied and provided below: Viscosity at 25°C (cP) 153.9Density (g / mL) 0.9352Refractive Index 1.51130Surface Tension (mN / m) 32.0Hydroxyl Value (mg KOH / g) 0.69Acid Value (mg KOH / g) 0.13

[0099] It is understood that the reaction conditions described above may be modified in order to isolate products with different values of n, such as, by altering the molar ratio between the reactants, altering the temperature or time of the reaction, or by employing standard techniques (such as distillation or chromatography) to separate fractions based on their molecular weight.

Claims

CLAIMSListing of Claims:

1. A hydrocarbon compound, wherein the hydrocarbon compound is a terpene oligomer (e.g., C10-C40), derived from, or derivable from, a terpene (e.g., a monocyclic or bicyclic monoterpene) via ene reaction coupling of said terpene, or via Diels-Alder cycloaddition of said terpene, or via Diels-Alder cycloaddition of a diene isomer of said terpene; or partially or fully saturated derivative thereof.

2. The compound of claim 1, wherein the compound is derived from, or derivable from, a terpene (e.g., a monocyclic or bicyclic monoterpene) via ene reaction coupling of said terpene.

3. The compound of claim 1, wherein the compound is derived from, or derivable from, a terpene (e.g., a diunsaturated monocyclic or bicyclic monoterpene) via Diels-Alder cycloaddition of said terpene.

4. The compound of claim 1, wherein the compound is derived from, or derivable from, a terpene (e.g., a monounsaturated bicyclic monoterpene) via isomerization of the terpene to a form a diunsaturated terpene derivative (e.g., a diunsaturated monocyclic monoterpene), followed by Diels- Alder cycloaddition of said diunsaturated terpene derivative.

5. The compound of any one of claims 1-4, wherein said terpene is a monoterpene (CIO hydrocarbon).

6. The compound of any one of claims 1-4, wherein said terpene is selected from the group consisting of alpha-pinene, beta-pinene, limonene, camphene, sabinene, 3-carene, alpha- thujene, beta-thujene, alpha-terpinene, beta-terpinene, gamma-terpinene, terpinolene, alpha-phellandrene, beta-phellandrene, gamma-murolene, longifolene, delta-cadinene, humulene, caryophyllene, taxadiene, curcumene, germacrene, and laurene.

7. The compound of claim 1, wherein said terpene is selected from the group consisting of beta-pinene and limonene.

8. The compound of any one of claims 1-4, wherein the compound is selected from the group consisting of:ppp ? ■ '■ pXc IJPrPYpyp^ ^xpPPtX pP^YyA y / jf Xx Pt® Ppp XkQt3 ^'''^ XXXx -K';^CC -OLGxX xp^ X D XIXJp V?\ / xX XX-O XX XXpT X )x> (J"PYx ' T "'><( A I xP / XX> / y \pxXctv ^oJL-;RAand / orX^Xlyy 'X^x^,^xxXxp J^y-xjjO^ ^ iXXXx^tzx^ CX^XjX^ ^XX^JX ^XXXX xXXxO 0^^^xx^ ^XxC^ cx^^^XX?^ otx^E^X^xy ^XJ>^^XX^y< y^CD^vI^—9. The compound of claim 1, wherein the terpene is beta-pinene and the compound is selected from the group consisting of:or mixtures thereof.

10. The compound of claim 1, wherein the terpene is beta-pinene and the compound is selected from the group consisting of:or mixtures thereof; provided that the compoundis in admixture with at least one other compound above.

11. The compound of claim 1, wherein the terpene is beta-pinene and the terpene oligomer hydrocarbon is selected from the group consisting of, or comprises a compound selected from the group consisting of:

12. The compound of claim 1, wherein the terpene is limonene and the terpene oligomer hydrocarbon is, or comprises, a limonene dimer selected from the group consisting of:tetramer derivative of any of the foregoing, or mixtures thereof.

13. The compound of claim 1, wherein the terpene is limonene and the terpene oligomer hydrocarbon is, or comprises, a hydrogenated limonene dimer selected from the group consisting of:foregoing, or mixtures thereof.

14. A composition comprising a compound according to any one of claims 1-13, or any mixtures thereof, in combination with at least one suitable solvent, carrier, or excipient, optionally wherein the composition is a cosmetic, pharmaceutical, or personal care composition.

15. The composition according to claim 14, wherein the composition is a fragrance, perfume, soap, pomander, cosmetic, toilet water, pre- and / or after-shave lotion, talcum powder, haircare product, body deodorant, anti-perspirant, shampoo, topical skin care, antimicrobial, mesogen, writing and / or printing ink, dye, pigment, paint or coating, skintone evening, anti-hyperpigmentation, anti-hypopigmentation, cross-linking, temporary stiffening, or permanent stiffening, insecticidal, insect repellant, insect attractant,pesticide, plasticizer, cleaning product, traction fluid, lubricating oil, lubricant, frictionmodifying, fuel, or oil field composition.

16. The composition according to claim 14 or 15. further comprising one or more cosmetically acceptable, pharmaceutically acceptable, or industrially acceptable excipients or carriers, for example, solvents, oils, surfactants, emollients, diluents, glidants, abrasives, humectants, plasticizers, catalysts, antioxidants, coloring agent, antibacterial agent, flavoring agent, fragrance agent, antiperspirant agent, antifungal agent, stabilizer or viscosity controlling agent.

17. A method for making a terpene oligomer hydrocarbon (e.g., C10-C40) comprising the steps of (a) exposing a terpene (e.g., a mono-terpene) to an acid catalyst (e.g., a solidphase acid catalyst), for a sufficient period of time to form one or more oligomers of the terpene (e.g., dimer, trimer, tetramer, etc.) by the ene-reaction or the Diels-Alder reaction, and (b) purifying or isolating one or more products, and optionally (c) hydrogenating one or more of the products (or a mixture thereof) to form one or more hydrogenated products.

18. A terpene oligomer hydrocarbon made according to the method of claim 17.

19. A terpene oligomer hydrocarbon mixture made according to the method of claim 17.